Wed Oct 23 07:08:17 UTC 2024: **Summary of Godavari Biorefineries IPO Announcement:**
1. **IPO Launch Details**: Godavari Biorefineries is set to launch an IPO worth Rs 554.75 crore, comprising a fresh issue of Rs 325 crore and an offer-for-sale of Rs 229.75 crore.
2. **Subscription Information**: The company will be listed on both BSE and NSE, with retail investors required to invest a minimum of Rs 14,784. Small NII investors must invest at least Rs 206,976, while large NII investors need a minimum of Rs 1,005,312.
3. **GMP and Pricing**: As of October 23, 2024, the IPO Grey Market Premium (GMP) is Rs 0, with a price band set between Rs 334 and Rs 352 per share.
4. **Historical Performance**: The company reported revenue of Rs 525.27 crore for the period ended June 30, 2024, but incurred a loss of Rs 26.11 crore post-tax. The total assets stand at Rs 1,554.62 crore, with a net worth of Rs 233.84 crore.
5. **Industry Position**: Godavari Biorefineries is a leading producer of ethanol-based chemicals, owning the world’s largest installed capacity for MPO and being one of two global manufacturers of natural 1,3-butanediol. The company also has a diverse product range including bio-based chemicals and energy.
6. **Research and Development**: With three DSIR-registered R&D centers and a team comprising eight PhD scientists, the company holds 18 patents and has numerous product registrations globally.
7. **Clientele and Presence**: Notable clients include Hershey India and Coca-Cola, serving markets in over 20 countries.
8. **Employee Base**: The firm employs 1,583 permanent workers across its two manufacturing units in Karnataka and Maharashtra.
9. **Future Plans**: The company aims to utilize the proceeds from the IPO to explore profitable opportunities.
10. **Application Deadline**: The cut-off time for IPO applications is October 25, 2024, by 5 PM, although brokers may close applications earlier.
This IPO offers a key opportunity for investors, but potential risks associated with the investment should be thoroughly evaluated.